Table 2. Correlation analysis of TMED2/3/4/9 mRNA levels and gene markers of immune cells in breast cancer.
Immune cells | Gene markers | TMED2 | TMED3 | TMED4 | TMED9 |
---|---|---|---|---|---|
T cell (general) | CD3D | −0.113# | −0.195# | −0.161# | −0.009 |
CD3E | −0.053 | −0.207# | −0.102# | −0.052 | |
CD2 | 0.001 | −0.201# | −0.081 | −0.028 | |
CD8+ T cell | CD8A | 0.008 | −0.206# | −0.013 | −0.075 |
CD8B | −0.098 | −0.152# | −0.084 | −0.031 | |
Tex | PD-1 (PDCD1) | −0.173# | −0.19# | −0.126# | 0.058 |
CTLA4 | −0.024 | −0.203# | −0.139# | 0.019 | |
LAG3 | −0.128# | −0.17# | −0.201# | 0.089 | |
TIM-3 (HAVCR2) | 0.186* | −0.061 | 0.042 | 0.137* | |
GZMB | −0.058 | −0.166# | −0.209# | 0.039 | |
B cell | CD19 | −0.132# | −0.143# | −0.106# | −0.048 |
CD79A | −0.101# | −0.149# | −0.109# | −0.073 | |
NK cell | KIR2DL3 | 0.031 | −0.12# | −0.054 | −0.017 |
KIR2DL4 | 0.014 | −0.134# | −0.083 | 0.002 | |
KIR3DL1 | 0.002 | −0.115# | −0.043 | 0.016 | |
KIR3DL2 | −0.027 | −0.135# | −0.109# | −0.041 | |
KIR2DS4 | 0.029 | −0.113# | −0.063 | −0.033 | |
DC | HLA-DPB1 | −0.193# | −0.064 | −0.096 | 0.119* |
HLA-DQB1 | −0.113# | −0.118# | −0.132# | 0.089 | |
HLA-DRA | 0.049 | −0.11# | −0.015 | 0.037 | |
BCDA-1 (CD1C) | −0.109# | −0.111# | 0.015 | −0.121# | |
BDCA-4 (NRP1) | 0.235* | −0.019 | 0.182* | −0.065 | |
TAM | CCL2 | 0.043 | −0.128# | −0.101# | 0.002 |
CD68 | 0.149* | −0.036 | 0.029 | 0.192* | |
IL10 | 0.197* | −0.093 | 0.016 | 0.162* | |
M1 macrophage | IRF5 | 0.056 | −0.05 | 0.15* | 0.18* |
COX2 (PTGS2) | 0.044 | −0.142# | −0.012 | −0.098 | |
M2 macrophage | CD163 | 0.202* | −0.075 | 0.113* | 0.199* |
VSIG4 | 0.092 | −0.031 | 0.072 | 0.133* | |
MS4A4A | 0.17* | −0.085 | 0.056 | 0.118* |
*, represents positive correlation (P<0.05 and Rho >0.1); whereas #, represents negative correlation (P<0.05 and Rho <−0.1). The regular numbers with colorless background indicate not significant. TMED, transmembrane p24 trafficking protein; mRNA, messenger RNA; DC, dendritic cells; NK, natural killer; TAM, tumor associated macrophages.